Oramed Pharmaceuticals
ORMP
#9078
Rank
C$0.23 B
Marketcap
C$5.86
Share price
3.48%
Change (1 day)
86.69%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): C$0.10 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of C$0.10 Billion, an increase over its 2024 earnings that were of -C$21.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.10 B-0.62%
2025 C$0.10 B-616.9%
2024 -C$21.22 Million-311.47%
2023 C$10.03 M-119.45%
2022 -C$51.58 Million39.17%
2021 -C$37.06 Million73.93%
2020 -C$21.31 Million18.53%
2019 -C$17.98 Million-16.62%
2018 -C$21.56 Million38.32%
2017 -C$15.59 Million12.51%
2016 -C$13.86 Million25.01%
2015 -C$11.09 Million18.18%
2014 -C$9.38 Million39.72%
2013 -C$6.72 Million46.4%
2012 -C$4.59 Million128.32%
2011 -C$2.01 Million-51.47%
2010 -C$4.14 Million35.21%
2009 -C$3.06 Million
2007 -C$4.82 Million607.04%
2006 -C$0.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$35.21 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$10.78 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.76 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$36.74 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$49.11 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel